Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: Changes linked to disease progression

Neurodegenerative Diseases

Volumn 8, Issue 4, 2011, Pages 252-258

  Ikeda, Ken ^a   Nakamura, Yoshikazu ^a   Kiyozuka, Tetsuhito ^b   Aoyagi, Joe ^b   Hirayama, Takehisa ^a   Nagata, Riya ^a   Ito, Hirono ^a   Iwamoto, Konosuke ^a   Murata, Kiyoko ^a   Yoshii, Yasuhiro ^a   Kawabe, Kiyokazu ^a   Iwasaki, Yasuo ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^b Mishuku Hospital   (Japan)

Author keywords

Antioxidant; Ferritin; Lipid; Oxidative stress; Paraoxonase 1; Parkinson's disease; Urate

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL; FERRITIN; IRON; LEVODOPA; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URATE;

AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DISEASE DURATION; ENZYME ACTIVITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SEROLOGY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE;

AGED; ARYLDIALKYLPHOSPHATASE; DISEASE PROGRESSION; FEMALE; FERRITINS; HUMANS; LIPIDS; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; URIC ACID;

EID: 79955806108     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000323265     Document Type: Article

References (29)

1. Morioka S, Sakata K, Yoshida S, Nakai E, Shiba M, Yoshimura N, Hashimoto T: Incidence of Parkinson disease in Wakayama, Japan. J Epidemiol 2002; 12: 403-407. (Pubitemid 44143848)
2. Jenner P: Oxidative stress in Parkinson's disease. Ann Neurol 2003; 53(suppl 3):S26-S36.
3. Wüllner U, Klockgether T: Inflammation in Parkinson's disease. J Neurol 2003; 250 (suppl 1):I35-I38. (Pubitemid 36255755)
4. Schapira AH: Mitochondrial dysfunction in Parkinson's disease. Cell Death Differ 2007; 14: 1261-1266. (Pubitemid 46965257)
5. Chen H, Mosley TH, Alonso A, Huang X: Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2009; 169: 1064-1069.
6. Weisskopf MG, O'Reilly E, Chen H, Schwarzschild MA, Ascherio A: Plasma urate and risk of Parkinson's disease. Am J Epidemiol 2007; 166: 561-567. (Pubitemid 47283643)
7. De Lau LM, Koudstaal PJ, Hofman A, Breteler MB: Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 2005; 58: 797-800. (Pubitemid 41552559)
8. Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM: Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol 1996; 144: 480-484. (Pubitemid 26296131)
9. Annanmaki T, Muuronen A, Murros: Low plasma uric acid level in Parkinson's disease. Mov Disord 2007; 22: 1133-1337.
10. Benmoyal-Segal L, Vander T, Shifman S, Bryk B, Ebstein RP, Marcus EL, Stessman J, Darvasi A, Herishanu Y, Friedman A, Soreq H: Acetylcholinesterase/ paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease. FASEB J 2005; 19: 452-454. (Pubitemid 40316547)
11. De Lau LM, Koudstaal PJ, Hofman A, Breteler MM: Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol 2006; 164: 998-1002. (Pubitemid 44729842)
12. Simon KC, Chen H, Schwarzschild M, Ascherio A: Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007; 69: 1688-1695. (Pubitemid 350287125)
13. Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J: Total cholesterol and the risk of Parkinson disease. Neurology 2008; 70: 1972-1979.
14. Lamperti E: Decreased concentration of lowdensity lipoprotein cholesterol in patients with Parkinson's disease. Clin Res 1991; 39: 401A.
15. Huang X, Chen H, Miller WC, Mailman RB, Woodard JL, Chen PC, Xiang D, Murrow RW, Wang YZ, Poole C: Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord 2007; 22: 377-381. (Pubitemid 46569693)
16. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
17. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
18. Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A; Parkinson Study Group PRECEPT Investigators, Hyson C, Gorbold E, Rudolph A, Kieburtz K, Fahn S, Gauger L, Goetz C, Seibyl J, Forrest M, Ondrasik J: Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol 2008: 65; 716-723. (Pubitemid 351831449)
19. Andreadou E, Nikolaou C, Gournaras F, Rentzos M, Boufidou F, Tsoutsou A, Zournas C, Zissimopoulos V, Vassilopoulos D: Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration. Clin Neurol Neurosurg 2009; 111: 724-728.
20. Aslan M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Gur M, Celik H, Erel O: Serum paraoxonase-1 activity in Helicobacter pylori -infected subjects. Atherosclerosis 2008; 196: 270-274.
21. Kondo I, Yamamoto M: Genetic polymorphism of paraoxonase-1 and susceptibility to Parkinson's disease. Brain Res 1998; 806: 271-273. (Pubitemid 29010502)
22. Zintzaras E, Hadjigeorgiou GM: Association of paraoxonase-1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet 2004; 49: 474-481. (Pubitemid 39314366)
23. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA: Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem 1995; 65, 710-716.
24. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD: Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991; 114: 1953-1975.
25. Wypijewska A, Galazka-Friedman J, Bauminger ER, Wszolek ZK, Schweitzer KJ, Dickson DW, Jaklewicz A, Elbaum D, Friedman A: Iron and reactive oxygen species activity in parkinsonian substantia nigra. Parkinsonism Relat Disord 2010; 16: 329-333.
26. Fukushima T, Tan X, Luo Y, Kanda H: Relationship between blood levels of heavy metals and Parkinson's disease in China. Neuroepidemiology 2010; 34: 18-24.
27. Musanti R, Parati E, Lamperti E, Ghiselli G: Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease. Biochem Med Metab Biol 1993; 49: 133-142. (Pubitemid 23197786)
28. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H: Dietary fats, cholesterol and iron as risk factors for Parkinson's disease. Parkinsonism Relat Disord 2009; 15: 47-52.
29. Miyake Y, Sasaki S, Tanaka K, Fukushima W, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Fukuoka Kinki Parkinson's Disease Study Group. Dietary fat intake and risk of Parkinson's disease: a case-control study in Japan. J Neurol Sci 2010; 288: 117-122.